PRODUCT
Summary
ATP2C1 peptide is used for blocking the activity of ATP2C1 antibody (catalog number GTX31834).
APPLICATION
Application Note
*Optimal dilutions/concentrations should be determined by the researcher.
Application |
Recommended Dilution |
Assay dependent |
Not tested in other applications.
PROPERTIES
Form
Liquid
Buffer
PBS, 0.1% BSA
Preservative
0.02% Sodium azide
Storage
Store as concentrated solution. Aliquot and store at -20ºC or below. Avoid freeze-thaw cycles.
Concentration
200 μg/ml (Please refer to the vial label for the specific concentration.)
Conjugation
Unconjugated
Note
For laboratory research use only. Not for any clinical, therapeutic, or diagnostic use in humans or animals. Not for animal or human consumption.
Purchasers shall not, and agree not to enable third parties to, analyze, copy, reverse engineer or otherwise attempt to determine the structure or sequence of the product.
TARGET
Synonyms
Atpase Secretory Pathway Ca2+ Transporting 1 , Atp2C1A , Bcpm , Hhd , Pmr1 , Spca1 , Hspca1 , Atp2C1
Background
The protein encoded by this gene belongs to the family of P-type cation transport ATPases. This magnesium-dependent enzyme catalyzes the hydrolysis of ATP coupled with the transport of calcium ions. Defects in this gene cause Hailey-Hailey disease, an autosomal dominant disorder. Alternatively spliced transcript variants encoding different isoforms have been identified. [provided by RefSeq, Aug 2011]
Research Area
REFERENCE
There are currently no references for ATP2C1 blocking peptide (GTX31834-PEP). Be the first to share your publications with this product.
REVIEW
There are currently no reviews for ATP2C1 blocking peptide (GTX31834-PEP). Be the first to share your experience with this product.